AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 193 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,365,000 | +307.5% | 39,629 | +296.0% | 0.01% | +233.3% |
| Q4 2019 | $335,000 | +58.0% | 10,008 | -1.4% | 0.00% | +50.0% |
| Q3 2019 | $212,000 | -8.6% | 10,148 | -8.8% | 0.00% | 0.0% |
| Q2 2019 | $232,000 | -8.7% | 11,126 | -2.0% | 0.00% | 0.0% |
| Q1 2019 | $254,000 | +2.0% | 11,358 | +9.3% | 0.00% | 0.0% |
| Q4 2018 | $249,000 | +24.5% | 10,396 | +41.8% | 0.00% | +100.0% |
| Q3 2018 | $200,000 | – | 7,334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|